SCHEMBL18017367

SCHEMBL18017367

COc1cccc(C)c1OBO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.42
TP53 P04637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ENPP2 Q13822 1/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA12 O43570 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
CA4 P22748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25962740 0.88 SMN1; SMN2 (0.48) SMN1; SMN2TP53KDM4EALDH1A1LMNA
SCHEMBL3437802 0.83 ALDH1A1 (0.42) SMN1; SMN2KDM4EALDH1A1LMNACYP3A4
SCHEMBL28221317 0.81 ALDH1A1 (0.40) SMN1; SMN2KDM4EALDH1A1LMNACYP3A4
SCHEMBL26816106 0.80 SMN1; SMN2 (0.50) SMN1; SMN2TP53KDM4EALDH1A1LMNA
SCHEMBL26764398 0.79 SMN1; SMN2 (0.41) SMN1; SMN2TP53KDM4EALDH1A1LMNA
SCHEMBL16437068 0.79 KMT2A (0.46) SMN1; SMN2TP53KDM4EALDH1A1LMNA
SCHEMBL134856 0.79 SMN1; SMN2 (0.52) SMN1; SMN2TP53KDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL28264941 0.77 SMN1; SMN2 (0.50) SMN1; SMN2TP53KDM4EALDH1A1LMNA
SCHEMBL14768539 0.76 TRPA1 (0.46) SMN1; SMN2TP53KDM4EALDH1A1LMNA
SCHEMBL23438 0.74 SMN1; SMN2 (0.52) SMN1; SMN2TP53KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018414-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-01-18 US disclosed
US-11795385-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-24 US disclosed
US-20160240800-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795385-B2 Organic electroluminescent materials and devices OXER1, OXSR1, OXGR1 SMN1; SMN2 2489/4885TP53 3283/4885KDM4E 1677/4885
US-20240018414-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, OXSR1, OXGR1 SMN1; SMN2 2489/4885TP53 3283/4885KDM4E 1677/4885
US-20160240800-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, TECR, OR10J3 SMN1; SMN2 2020/4885TP53 3291/4885KDM4E 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.